Clinical trialNCT02527434CompletedPhase 2Interventional

Study of Tremelimumab in Patients With Advanced Solid Tumors

SponsorAstraZenecaEnrollment64Pancreatic Ductal AdenocarcinomaTriple-negative Breast CancerUrothelial Bladder Cancer

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Sharma Padmanee, MD, PhD
Anderson Cancer Center, the University of Texas
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium

Research Site
Brussels, Belgium
Research Site
Charleroi, Belgium
Research Site
Wilrijk, Belgium

Netherlands

Research Site
Groningen, Netherlands
Research Site
Utrecht, Netherlands

Poland

Research Site
Gdansk, Poland
Research Site
Lodz, Poland

South Korea

Research Site
Daejeon, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea

United States

Research Site
San Francisco, California, United States
Research Site
Memphis, Tennessee, United States
Research Site
Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 2 Nov 2015
Primary completion: 17 Feb 2018
Completion: 28 Mar 2023
Last update posted: 15 Nov 2023
Registered enrollment: 64
Registry id: NCT02527434

Cross-registrations

EU-CTR / CTIS (EudraCT)2015-002934-32

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.